MLTX
Price
$13.35
Change
+$0.83 (+6.63%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
938.02M
84 days until earnings call
Intraday BUY SELL Signals
NEVPF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
45.13M
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs NEVPF

Header iconMLTX vs NEVPF Comparison
Open Charts MLTX vs NEVPFBanner chart's image
MoonLake Immunotherapeutics
Price$13.35
Change+$0.83 (+6.63%)
Volume$33.91K
Capitalization938.02M
Abliva AB
PriceLoading...
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
MLTX vs NEVPF Comparison Chart in %
MLTX
Daily Signal:
Gain/Loss:
NEVPF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MLTX vs. NEVPF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and NEVPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (MLTX: $12.54 vs. NEVPF: $0.03)
Brand notoriety: MLTX and NEVPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 12% vs. NEVPF: 100%
Market capitalization -- MLTX: $938.02M vs. NEVPF: $45.13M
MLTX [@Biotechnology] is valued at $938.02M. NEVPF’s [@Biotechnology] market capitalization is $45.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whileNEVPF’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • NEVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than NEVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 4 TA indicator(s) are bullish while NEVPF’s TA Score has 1 bullish TA indicator(s).

  • MLTX’s TA Score: 4 bullish, 3 bearish.
  • NEVPF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than NEVPF.

Price Growth

MLTX (@Biotechnology) experienced а -7.86% price change this week, while NEVPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($938M) has a higher market cap than NEVPF($45.1M). NEVPF YTD gains are higher at: -22.222 vs. MLTX (-76.842). NEVPF has higher annual earnings (EBITDA): -87.99M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. NEVPF (32.7M). MLTX (0) and NEVPF (0) have equivalent revenues.
MLTXNEVPFMLTX / NEVPF
Capitalization938M45.1M2,080%
EBITDA-196.98M-87.99M224%
Gain YTD-76.842-22.222346%
P/E RatioN/AN/A-
Revenue00-
Total Cash425M32.7M1,300%
Total Debt75.8MN/A-
FUNDAMENTALS RATINGS
NEVPF: Fundamental Ratings
NEVPF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
6

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXNEVPF
RSI
ODDS (%)
Bullish Trend 6 days ago
56%
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
57%
N/A
Momentum
ODDS (%)
Bullish Trend 6 days ago
73%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 6 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
13%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
73%
N/A
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
59%
N/A
Aroon
ODDS (%)
Bullish Trend 6 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
NEVPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMCIX25.54N/A
N/A
Calvert Small/Mid-Cap I
JMCRX22.11N/A
N/A
James Micro Cap
LOMGX36.60N/A
N/A
Lord Abbett Growth Opportunities F3
WLGAX39.30N/A
N/A
Nomura Large Cap Growth A
BCSFX24.61N/A
N/A
Brown Capital Mgmt Intl Sm Co Instl

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-5.36%
KALA - MLTX
87%
Closely correlated
-16.54%
IOBT - MLTX
75%
Closely correlated
-7.11%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-3.15%
NUVL - MLTX
48%
Loosely correlated
-1.37%
More

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been closely correlated with MLTX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NEVPF jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
MLTX - NEVPF
70%
Closely correlated
-5.36%
IMA - NEVPF
66%
Loosely correlated
-7.31%
ATYR - NEVPF
65%
Loosely correlated
-4.02%
REPL - NEVPF
64%
Loosely correlated
+3.19%
SPRB - NEVPF
61%
Loosely correlated
+8.47%
More